The Italian innovation in Radiopharmaceuticals.
ITELPHARMA contributes to the advancement of nuclear medicine through research, production and collaboration with healthcare, industrial and research stakeholders.
Austria Center Vienna
Reimagining the future of Radiopharmaceuticals
ITELPHARMA is the ITEL Group company dedicated to the production and distribution of radiopharmaceuticals. We work alongside hospitals, research centres and industrial partners to support the evolution of nuclear medicine with innovative, reliable and clinically-oriented solutions.
From oncology diagnostics to theranostic applications, we develop and manufacture a complete range of radiotracers for modern nuclear medicine — combining the highest GMP standards, full traceability and a nationwide network of production sites across Italy.
Join us at EANM ’26 in Vienna to discover how ITELPHARMA is shaping the future of precision medicine, theranostics and the next generation of radiotracers.
A new standard in Italian Radiopharmaceuticals
An integrated approach across the entire value chain — research, production and clinical distribution — designed to support hospitals, IRCCS and research centres with the highest standards of quality and reliability.
Integrated research, development and production capabilities
Highest international GMP standards with full traceability
Nationwide network of certified production sites across Italy
Expanding portfolio for diagnostic and theranostic applications
Active partnerships with hospitals, IRCCS and research consortia
Discover ITELPHARMA
Want to learn more about our radiopharmaceutical portfolio, production network and research pipeline? Register now to access our exclusive brochure and technical materials.
Visit us
ITELPHARMA is here at EANM ’26
Here’s what you can expect:
- Discover our full radiotracer portfolio for diagnostic and theranostic applications
- Insights into our nationwide GMP production network across Italy
- Updates on our R&D pipeline and active partnerships in nuclear medicine
- Materials, Q&A, and live discussions with our scientific team
Let’s meet in Vienna
Driving the future of nuclear medicine, together.
Book your 1:1 session now and talk directly with our specialists about radiopharmaceuticals, theranostics and clinical partnerships.
Find us in Vienna
Venue
Austria Center Vienna (ACV)
Bruno-Kreisky-Platz 1, 1220 Vienna, Austria
Date
17 – 21 October 2026
39th EANM Annual Congress
Language
English
The official language of EANM ’26 is English.
Let’s stay in touch
Our team is at your disposal for any information about our radiopharmaceutical portfolio, production capabilities, and partnership opportunities. Reach out before, during, or after EANM ’26.